Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework for the NHS London Region, Branded Medicines - Tranche A

NHS England

This public procurement record has 2 releases in its history.

Award

15 Sep 2020 at 14:26

Award Notice
Tender

12 Mar 2020 at 10:51

Tender Notice
Summary of the contracting process

NHS England is conducting a public procurement process for the "NHS Framework for the NHS London Region, Branded Medicines - Tranche A", which is classified under pharmaceutical products. The contract process is currently in the award stage, having been completed on 15th September 2020, with contract performance spanning from 1st September 2020 to 31st August 2022. The authority has outlined options for extension, and the total estimated value of the procurement is approximately £602 million. The procurement method utilised is an open procedure, suitable for suppliers across multiple regions of the United Kingdom.

This tender offers significant growth opportunities for pharmaceutical companies, particularly those that focus on branded medicines, cytokine modulators, and HIV medications such as Dolutegravir and Lamivudine. Small and medium-sized enterprises (SMEs) are especially encouraged to apply, as the procurement process is designed to accommodate diverse suppliers. Businesses with expertise in pharmaceutical products, particularly those who can demonstrate capacity for large-scale supply, would be well-suited to compete for this substantial contract.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework for the NHS London Region, Branded Medicines - Tranche A

Notice Description

NHS Framework for the NHS London Region, Branded Medicines - Tranche A, Annual Tranche - Cytokine Modulators and other products, and Dolutegravir / Lamivudine Offer reference number: CM/PHR/16/5516 CM/PHR/16/5516/01 - London Tranche A - 1 September 2020 to 31 August 2022 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months CM/PHR/16/5516/02 - London Annual Tranche - Cytokine Modulators and other products - 1 September 2020 to 31 August 2021 with an option to extend (at the Authority's discretion) for a period or periods up to a total of 12 months CM/PHR/16/5516/03 - NHS Framework agreement for the supply of Dolutegravir / Lamivudine - North of England - 1 September 2020 - 28 February 2021, South of England - 1 September 2020 - 31 August 2021, Midlands & East - 1 September 2020 - 28 February 2022, all with an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-20ae12c6-3ba8-40bb-b423-51a2c2de6a67
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/0e6f8f87-365c-4e84-90bf-6eb21339ba33
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£301,101,314 £100M-£1B
Lots Value
Not specified
Awards Value
£191,062,951 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
15 Sep 20205 years ago
Submission Deadline
15 Apr 2020Expired
Future Notice Date
Not specified
Award Date
17 Jun 20206 years ago
Contract Period
1 Sep 2020 - 31 Aug 2022 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
28
Supplier Names

AbbVie Ltd

Accord UK Ltd

Allergan Ltd

Amgen Ltd

Biogen Ltd.

Bristol Myers Squibb Pharmaceutical Ltd

Celltrion Healthcare United Kingdom Limited

ELI LILLY & COMPANY LIMITED

Ferring Pharmaceuticals Limited

Gilead Sciences

Ipsen Limited

Janssen-Cilag Ltd

Merck

Merck Sharp & Dohme Ltd

Merz Pharma UK Ltd

Napp Pharmaceuticals Limited

Novartis Pharmaceuticals UK Ltd

Novo Nordisk Ltd

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Limited

Sandoz Ltd

Takeda UK Ltd

Teva UK Limited

Thornton and Ross Ltd

UCB Pharma Ltd

Vifor Pharma UK Limited

ViiV Healthcare Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...